Literature DB >> 3284640

Identification of the human papillomavirus type 18 E6 and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in vitro.

A Schneider-Gädicke1, S Kaul, E Schwarz, H Gausepohl, R Frank, G Bastert.   

Abstract

We recently reported the transcription patterns of human papillomavirus (HPV) type 18 sequences in human cervical carcinoma cell lines. The open reading frames (ORFs) E6* and E6 represent the 5'-terminal cistrons in HPV18 mRNAs. ORF E6* was assumed to be specific for HPV types associated with genital carcinomas. To identify the predicted gene product, ORF E6* from a HeLa cDNA clone was expressed as an MS2 fusion protein in Escherichia coli. The C-terminal 23 amino acid residues were chemically synthesized. A panel of monoclonal antibodies was generated, recognizing E6* and E6* plus E6, respectively. In human cervical carcinoma cell lines grown in vitro these monoclonal antibodies specifically immunoprecipitate the putative Mr 17,000 and 18,000 HPV18 E6 proteins in nuclear protein fractions. In a HPV18 DNA containing human cervical carcinoma established in nude mice, these monoclonal antibodies specifically immunoprecipitate a polypeptide with a molecular weight of 6500 as predicted for the HPV18 ORF E6* gene product in a nuclear protein fraction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284640

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription.

Authors:  Daniel L Miller; Brenden Rickards; Michael Mashiba; Wenying Huang; S J Flint
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

2.  Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16.

Authors:  L Sherman; R Schlegel
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.

Authors:  Carina H Storrs; Saul J Silverstein
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 4.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Human papillomavirus type 18 E6*, E6, and E7 protein synthesis in cell-free translation systems and comparison of E6 and E7 in vitro translation products to proteins immunoprecipitated from human epithelial cells.

Authors:  B Roggenbuck; P M Larsen; S J Fey; D Bartsch; L Gissmann; E Schwarz
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture.

Authors:  S A Sedman; M S Barbosa; W C Vass; N L Hubbert; J A Haas; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 7.  Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.

Authors:  Niladri Ganguly; Suraj P Parihar
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

8.  Differential localization of HPV16 E6 splice products with E6-associated protein.

Authors:  Kulthida Vaeteewoottacharn; Siriphatr Chamutpong; Mathurose Ponglikitmongkol; Peter C Angeletti
Journal:  Virol J       Date:  2005-06-16       Impact factor: 4.099

9.  The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression.

Authors:  Koceila Meznad; Philippe Paget-Bailly; Elise Jacquin; Anne Peigney; François Aubin; Michaël Guittaut; Christiane Mougin; Jean-Luc Prétet; Aurélie Baguet
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

10.  Correlation between tumorigenicity and expression levels or splicing patterns of transcripts of the human papillomavirus type 16 E6 gene.

Authors:  T Inoue; S Kyo; T Kiyono; M Ishibashi; H Ishiwatari; Y I Hwang; M Yutsudo; A Hakura
Journal:  Jpn J Cancer Res       Date:  1994-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.